Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Dost

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Epilepsy Research|December 22, 1999
The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparationR Dost, C Rundfeldt
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 10, 2004
The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activationR Dost, A Rostock, C Rundfeldt
Cytometry|January 1, 1990
Increased light scattering resolution facilitates multidimensional flow cytometric analysisL W Terstappen, R A Mickaels, R Dost, et al.
British Journal of Pharmacology|November 27, 2012
The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potentialA Boehlen, M Schwake, R Dost, et al.
ACS Photonics|August 27, 2025
Electro-Mechanically Tunable, Waveguide-Coupled Photonic-Crystal Cavities with Embedded Quantum DotsL A F Brunswick, L Hallacy, R Dost, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Epilepsy Research|December 22, 1999
The anticonvulsant retigabine potently suppresses epileptiform discharges in the low Ca ++ and low Mg++ model in the hippocampal slice preparationR Dost, C Rundfeldt
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 10, 2004
The anti-hyperalgesic activity of retigabine is mediated by KCNQ potassium channel activationR Dost, A Rostock, C Rundfeldt
Cytometry|January 1, 1990
Increased light scattering resolution facilitates multidimensional flow cytometric analysisL W Terstappen, R A Mickaels, R Dost, et al.
British Journal of Pharmacology|November 27, 2012
The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potentialA Boehlen, M Schwake, R Dost, et al.
ACS Photonics|August 27, 2025
Electro-Mechanically Tunable, Waveguide-Coupled Photonic-Crystal Cavities with Embedded Quantum DotsL A F Brunswick, L Hallacy, R Dost, et al.
Pageof 1